TwinEdge Bioscience partners with Phost'In Therapeutics.
We are excited to announce a new collaboration between TwinEdge Bioscience and Phost'In Therapeutics.
This partnership brings together TwinEdge's Digital Avatar platform, which generates population-scale insights through AI-driven and mechanistically informed digital patient tumor models, with Phost'In's pioneering work in glycocalyx modification and N-glycosylation-targeted therapeutics.
By combining advanced in silico patient modeling with a novel therapeutic approach designed to unmask tumors and promote anti-cancer immune responses, we aim to deepen our understanding of treatment response and generate new translational insights in oncology.
We believe the future of drug development lies at the intersection of innovative biology and advanced computational technologies. This collaboration represents an exciting opportunity to explore how these complementary approaches can help accelerate the development of next-generation cancer therapies.
We're looking forward to working together and sharing more as the collaboration progresses.
This partnership brings together TwinEdge's Digital Avatar platform, which generates population-scale insights through AI-driven and mechanistically informed digital patient tumor models, with Phost'In's pioneering work in glycocalyx modification and N-glycosylation-targeted therapeutics.
By combining advanced in silico patient modeling with a novel therapeutic approach designed to unmask tumors and promote anti-cancer immune responses, we aim to deepen our understanding of treatment response and generate new translational insights in oncology.
We believe the future of drug development lies at the intersection of innovative biology and advanced computational technologies. This collaboration represents an exciting opportunity to explore how these complementary approaches can help accelerate the development of next-generation cancer therapies.
We're looking forward to working together and sharing more as the collaboration progresses.
